Cancer Genetics, Inc. to Receive $1.0 Million in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program Genetics Investing
ToolGen Highlights Study Results Demonstrating Utility of AAV-Compatible Cas9 System in vivo Genome Editing Genetics Investing
Myriad’s BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer Patients with Improved Outcomes from AstraZeneca's PARP Inhibitor, Olaparib Genetics Investing
Alder BioPharmaceuticals to Host Conference Call to Discuss Fourth Quarter and Full Year 2016 Financial and Operating Results Biotech Investing
Cancer Genetics' Hereditary Breast & Ovarian Cancer Panel Selected by Global Biopharma to Power 1,000+ Patient Clinical Study Genetics Investing
Editas Medicine Announces U.S. Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR Interference Genetics Investing
Aevi Genomic Medicine Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of AEVI-001 in 22q Deletion Syndrome Genetics Investing
uniQure Announces FDA Breakthrough Therapy Designation for AMT-060 in Hemophilia B Genetics Investing
